Goldman Sachs Group Inc Viatris Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Viatris Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,694,770 shares of VTRS stock, worth $58.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,694,770
Previous 3,073,804 52.73%
Holding current value
$58.8 Million
Previous $32.7 Million 66.82%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$10.32 - $12.13 $16.7 Million - $19.7 Million
1,620,966 Added 52.73%
4,694,770 $54.5 Million
Q2 2024

Aug 13, 2024
SELL
$10.05 - $12.02 $250,365 - $299,442
-24,912 Reduced 0.8%
3,073,804 $32.7 Million
Q1 2024

May 15, 2024
SELL
$11.27 - $13.53 $11.9 Million - $14.2 Million
-1,052,142 Reduced 25.35%
3,098,716 $37 Million
Q4 2023

Feb 13, 2024
SELL
$8.77 - $10.85 $1.38 Million - $1.71 Million
-157,273 Reduced 3.65%
4,150,858 $45 Million
Q3 2023

May 14, 2024
BUY
$9.59 - $11.35 $1.51 Million - $1.79 Million
157,273 Added 3.79%
4,308,131 $42.5 Million
Q3 2023

Nov 14, 2023
BUY
$9.59 - $11.35 $10.4 Million - $12.3 Million
1,081,911 Added 33.53%
4,308,131 $42.5 Million
Q2 2023

May 14, 2024
SELL
$9.02 - $10.29 $19.1 Million - $21.8 Million
-2,120,014 Reduced 39.65%
3,226,220 $32.2 Million
Q2 2023

Aug 14, 2023
SELL
$9.02 - $10.29 $19.1 Million - $21.8 Million
-2,120,014 Reduced 39.65%
3,226,220 $32.2 Million
Q1 2023

May 14, 2024
BUY
$9.2 - $12.26 $18.6 Million - $24.8 Million
2,021,278 Added 60.79%
5,346,234 $51.4 Million
Q1 2023

May 11, 2023
BUY
$9.2 - $12.26 $18.6 Million - $24.8 Million
2,021,278 Added 60.79%
5,346,234 $51.4 Million
Q4 2022

May 14, 2024
SELL
$8.72 - $11.56 $36.6 Million - $48.6 Million
-4,202,178 Reduced 55.83%
3,324,956 $37 Million
Q4 2022

Feb 13, 2023
SELL
$8.72 - $11.56 $36.6 Million - $48.6 Million
-4,202,178 Reduced 55.83%
3,324,956 $37 Million
Q3 2022

May 14, 2024
BUY
$8.48 - $11.13 $502,847 - $659,986
59,298 Added 0.79%
7,527,134 $64.1 Million
Q3 2022

Nov 10, 2022
BUY
$8.48 - $11.13 $502,847 - $659,986
59,298 Added 0.79%
7,527,134 $64.1 Million
Q2 2022

May 14, 2024
BUY
$9.95 - $12.27 $33 Million - $40.7 Million
3,316,978 Added 79.91%
7,467,836 $78.2 Million
Q2 2022

Aug 15, 2022
SELL
$9.95 - $12.27 $21.1 Million - $26 Million
-2,120,633 Reduced 22.12%
7,467,836 $78.2 Million
Q1 2022

May 16, 2022
BUY
$9.81 - $15.4 $2.12 Million - $3.33 Million
216,454 Added 2.31%
9,588,469 $104 Million
Q4 2021

Feb 14, 2022
BUY
$12.09 - $14.68 $7.03 Million - $8.54 Million
581,547 Added 6.62%
9,372,015 $127 Million
Q3 2021

Nov 10, 2021
BUY
$13.25 - $15.13 $116 Million - $133 Million
8,790,468 New
8,790,468 $119 Million

Others Institutions Holding VTRS

# of Institutions
1,102
Shares Held
933M
Call Options Held
2.71M
Put Options Held
2.4M
View Full List

About Viatris Inc

VTRS Quotes by TradingView
  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email